An Israeli doctor in Padua tells Zman Yisrael, The Times of Israel’s Hebrew-language sister site, about treatments that have been effective in Italy.
“In the past few days, people have begun to recover, in part due to new medications and also as a result of the fact that it takes some two weeks to recover from the virus,” says Carmi Sheffer.
He attributes the high death rates in Italy to the spread within geriatric hospitals. “The moment the virus arrives in a place where an elderly population is concentrated, it spreads like wildfire,” he says.
In Padua, the autoimmune medicine Tocilizumab has proven effective, but can only be used once established that no other viruses are present in the patients’ bodies, he says. The hospital where he works has also seen positive results from the antiviral drug Remdesivir, he says.
“We will control the virus and flatten the curve within a few weeks, but the closure will continue until June,” he predicts. “Italy is ahead of Israel by something like a month, so in my opinion, [in Israel] it will end only in July.”
But he also predicts that Israel could see soaring death rates, like Italy.
“I do not think the Israeli health care system is prepared for an outbreak on this scale. Israel’s advantage is the army, which can build field hospitals to treat mild cases, which is should,” he says.
Help us report truthfully on social media
As a multimedia journalist, my job is to take the quality, fact-based journalism produced by The Times of Israel newsroom and make it accessible across every platform — from Instagram posts to podcasts to short-form videos.
This is how many, especially young people, consume news these days. But misinformation is rampant on social media. Our team at ToI produces accurate, responsible short-form reporting on Israel and the Jewish world.
If you believe in the importance of factual social media journalism, please consider joining our reader support group, The Times of Israel Community. Your financial support is essential to sustain responsible multimedia reporting.
— Gabriella Jacobs, multimedia journalist
Support our work
Support our work
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this